MARKET

ADMP

ADMP

Adamis Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3660
-0.0489
-11.79%
After Hours: 0.4000 +0.034 +9.29% 19:33 03/27 EDT
OPEN
0.4000
PREV CLOSE
0.4149
HIGH
0.4069
LOW
0.3600
VOLUME
809.71K
TURNOVER
--
52 WEEK HIGH
2.324
52 WEEK LOW
0.2700
MARKET CAP
26.88M
P/E (TTM)
-0.4911
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ADMP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ADMP stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.

EPS

ADMP News

More
  • Adamis Pharma down 14% on equity offering
  • Seeking Alpha - Article · 02/21 14:51
  • Adamis Pharma Prices 11.6M Common Stock, Warrants Offering At $0.58/Unit
  • Benzinga · 02/21 14:15
  • Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
  • GlobeNewswire · 02/21 14:15
  • Adamis Pharmaceuticals: Waiting For The Next Move
  • Seeking Alpha - Article · 02/20 19:17

Industry

Pharmaceuticals
-0.41%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About ADMP

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.
More

Webull offers kinds of Adamis Pharmaceuticals Corp stock information, including NASDAQ:ADMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMP stock news, and many more online research tools to help you make informed decisions.